RecruitingNCT06482073

Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care

Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (INTERCEPTioN for Suspected Lung Cancer)for Suspected Lung Cancer)

Sponsor

Mayo Clinic

Enrollment

250 participants

Start Date

Jun 24, 2024

Study Type

OBSERVATIONAL

Conditions

Lung Carcinoma Metastatic Malignant Neoplasm in the Lung

Summary

This study evaluates the effectiveness of tumor samples in providing information about hereditary or cancer specific genetic variants that may have a role in diagnosis of cancer and to develop genetic results and medical record databank for future studies.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is using advanced molecular testing on blood, saliva, and tissue samples from people suspected of having lung cancer to see if genetic analysis can improve how early and accurately lung cancer is diagnosed. Researchers hope this approach can help personalize care before or alongside standard testing like bronchoscopy. **You may be eligible if...** - You are 18 or older - You are already scheduled for a bronchoscopy (a procedure to look inside your airways) as part of standard care - You have a moderate-to-high clinical risk of lung cancer based on your symptoms, scans, or history - You can provide a blood or saliva sample and archived tissue **You may NOT be eligible if...** - You are pregnant - You are currently incarcerated - You had comprehensive genetic testing (40+ gene panel) within the past year - You had comprehensive tumor genetic testing (250+ genes) within the past year Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.